Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 106

1.

Granulocytic Myeloid Derived Suppressor Cells Expansion during Active Pulmonary Tuberculosis Is Associated with High Nitric Oxide Plasma Level.

El Daker S, Sacchi A, Tempestilli M, Carducci C, Goletti D, Vanini V, Colizzi V, Lauria FN, Martini F, Martino A.

PLoS One. 2015 Apr 16;10(4):e0123772. doi: 10.1371/journal.pone.0123772. eCollection 2015.

2.

Diagnostic Values of the QuantiFERON-TB Gold In-Tube Assay Carried out in China for Diagnosing Pulmonary Tuberculosis.

Xia H, Wang X, Li F, Longuet C, Vernet G, Goletti D, Zhao Y, Lagrange PH.

PLoS One. 2015 Apr 13;10(4):e0121021. doi: 10.1371/journal.pone.0121021. eCollection 2015.

3.

Towards tuberculosis elimination: an action framework for low-incidence countries.

Lönnroth K, Migliori GB, Abubakar I, D'Ambrosio L, de Vries G, Diel R, Douglas P, Falzon D, Gaudreau MA, Goletti D, González Ochoa ER, LoBue P, Matteelli A, Njoo H, Solovic I, Story A, Tayeb T, van der Werf MJ, Weil D, Zellweger JP, Abdel Aziz M, Al Lawati MR, Aliberti S, Arrazola de Oñate W, Barreira D, Bhatia V, Blasi F, Bloom A, Bruchfeld J, Castelli F, Centis R, Chemtob D, Cirillo DM, Colorado A, Dadu A, Dahle UR, De Paoli L, Dias HM, Duarte R, Fattorini L, Gaga M, Getahun H, Glaziou P, Goguadze L, Del Granado M, Haas W, Järvinen A, Kwon GY, Mosca D, Nahid P, Nishikiori N, Noguer I, O'Donnell J, Pace-Asciak A, Pompa MG, Popescu GG, Robalo Cordeiro C, Rønning K, Ruhwald M, Sculier JP, Simunović A, Smith-Palmer A, Sotgiu G, Sulis G, Torres-Duque CA, Umeki K, Uplekar M, van Weezenbeek C, Vasankari T, Vitillo RJ, Voniatis C, Wanlin M, Raviglione MC.

Eur Respir J. 2015 Apr;45(4):928-52. doi: 10.1183/09031936.00214014.

4.

Risk Assessment of Tuberculosis in Contacts by IFN-γ Release Assays. A Tuberculosis Network European Trials Group Study.

Zellweger JP, Sotgiu G, Block M, Dore S, Altet N, Blunschi R, Bogyi M, Bothamley G, Bothe C, Codecasa L, Costa P, Dominguez J, Duarte R, Fløe A, Fresard I, García-García JM, Goletti D, Halm P, Hellwig D, Henninger E, Heykes-Uden H, Horn L, Kruczak K, Latorre I, Pache G, Rath H, Ringshausen FC, Ruiz AS, Solovic I, Souza-Galvão ML, Widmer U, Witte P, Lange C; TBNET.

Am J Respir Crit Care Med. 2015 May 15;191(10):1176-84. doi: 10.1164/rccm.201502-0232OC.

PMID:
25763458
5.

Immune Status and Serial Quantiferon-TB Gold In-Tube Screening for Latent Mycobacterium tuberculosis Infection Among HIV-Infected Persons in a Country With a Low Tuberculosis Incidence.

Sañé Schepisi M, Parracino MP, Mammone A, Bellagamba R, Pinnetti C, Cicalini S, Sampaolesi A, Ammassari A, Goletti D, Girardi E.

J Infect Dis. 2015 Jun 1;211(11):1852-3. doi: 10.1093/infdis/jiv038. Epub 2015 Jan 26. No abstract available.

PMID:
25628342
6.

Guidance for the management of patients with latent tuberculosis infection requiring biologic therapy in rheumatology and dermatology clinical practice.

Cantini F, Nannini C, Niccoli L, Iannone F, Delogu G, Garlaschi G, Sanduzzi A, Matucci A, Prignano F, Conversano M, Goletti D; SAFEBIO (Italian multidisciplinary task force for screening of tuberculosis before and during biologic therapy).

Autoimmun Rev. 2015 Jun;14(6):503-509. doi: 10.1016/j.autrev.2015.01.011. Epub 2015 Jan 21. Review.

PMID:
25617816
7.

IL-4 specific-response in whole blood associates with human Cystic Echinococcosis and cyst activity.

Petrone L, Vanini V, Petruccioli E, Ettorre GM, Busi Rizzi E, Schininà V, Girardi E, Ludovisi A, Gómez-Morales MÁ, Pozio E, Teggi A, Goletti D.

J Infect. 2015 Mar;70(3):299-306. doi: 10.1016/j.jinf.2014.10.009. Epub 2014 Oct 22.

PMID:
25444973
8.

Combined use of Mycobacterium tuberculosis-specific CD4 and CD8 T-cell responses is a powerful diagnostic tool of active tuberculosis.

Rozot V, Patrizia A, Vigano S, Mazza-Stalder J, Idrizi E, Day CL, Perreau M, Lazor-Blanchet C, Ohmiti K, Goletti D, Bart PA, Hanekom W, Scriba TJ, Nicod L, Pantaleo G, Harari A.

Clin Infect Dis. 2015 Feb 1;60(3):432-7. doi: 10.1093/cid/ciu795. Epub 2014 Oct 31.

9.

False-negative interferon-γ release assay results in active tuberculosis: a TBNET study.

de Visser V, Sotgiu G, Lange C, Aabye MG, Bakker M, Bartalesi F, Brat K, Chee CB, Dheda K, Dominguez J, Eyuboglu F, Ghanem M, Goletti D, Dilektasli AG, Guglielmetti L, Koh WJ, Latorre I, Losi M, Polanova M, Ravn P, Ringshausen FC, Rumetshofer R, de Souza-Galvão ML, Thijsen S, Bothamley G, Bossink A; TBNET.

Eur Respir J. 2015 Jan;45(1):279-83. doi: 10.1183/09031936.00120214. Epub 2014 Oct 30. No abstract available.

PMID:
25359336
10.

Risk assessment of tuberculosis in immunocompromised patients. A TBNET study.

Sester M, van Leth F, Bruchfeld J, Bumbacea D, Cirillo DM, Dilektasli AG, Domínguez J, Duarte R, Ernst M, Eyuboglu FO, Gerogianni I, Girardi E, Goletti D, Janssens JP, Julander I, Lange B, Latorre I, Losi M, Markova R, Matteelli A, Milburn H, Ravn P, Scholman T, Soccal PM, Straub M, Wagner D, Wolf T, Yalcin A, Lange C; TBNET.

Am J Respir Crit Care Med. 2014 Nov 15;190(10):1168-76. doi: 10.1164/rccm.201405-0967OC.

PMID:
25303140
11.

HBV Reactivation in Patients Treated with Antitumor Necrosis Factor-Alpha (TNF-α) Agents for Rheumatic and Dermatologic Conditions: A Systematic Review and Meta-Analysis.

Cantini F, Boccia S, Goletti D, Iannone F, Leoncini E, Panic N, Prignano F, Gaeta GB.

Int J Rheumatol. 2014;2014:926836. doi: 10.1155/2014/926836. Epub 2014 Jul 7. Review.

12.

Polyfunctional T-cells and effector memory phenotype are associated with active TB in HIV-infected patients.

Chiacchio T, Petruccioli E, Vanini V, Cuzzi G, Pinnetti C, Sampaolesi A, Antinori A, Girardi E, Goletti D.

J Infect. 2014 Dec;69(6):533-45. doi: 10.1016/j.jinf.2014.06.009. Epub 2014 Jun 26.

PMID:
24975174
13.

A toolbox for tuberculosis (TB) diagnosis: an Indian multi-centric study (2006-2008); evaluation of serological assays based on PGL-Tb1 and ESAT-6/CFP10 antigens for TB diagnosis.

Lagrange PH, Thangaraj SK, Dayal R, Deshpande A, Ganguly NK, Girardi E, Joshi B, Katoch K, Katoch VM, Kumar M, Lakshmi V, Leportier M, Longuet C, Malladi SV, Mukerjee D, Nair D, Raja A, Raman B, Rodrigues C, Sharma P, Singh A, Singh S, Sodha A, Kabeer BS, Vernet G, Goletti D.

PLoS One. 2014 May 5;9(5):e96367. doi: 10.1371/journal.pone.0096367. eCollection 2014.

14.

Restarting biologics and management of patients with flares of inflammatory rheumatic disorders or psoriasis during active tuberculosis treatment.

Cantini F, Prignano F, Goletti D.

J Rheumatol Suppl. 2014 May;91:78-82. doi: 10.3899/jrheum.140106. Review.

PMID:
24789004
15.
16.

Adalimumab, etanercept, infliximab, and the risk of tuberculosis: data from clinical trials, national registries, and postmarketing surveillance.

Cantini F, Niccoli L, Goletti D.

J Rheumatol Suppl. 2014 May;91:47-55. doi: 10.3899/jrheum.140102. Review.

PMID:
24789000
17.
18.

The spectrum of tuberculosis infection: new perspectives in the era of biologics.

Delogu G, Goletti D.

J Rheumatol Suppl. 2014 May;91:11-6. doi: 10.3899/jrheum.140097. Review.

PMID:
24788995
19.

Biologics and tuberculosis risk: the rise and fall of an old disease and its new resurgence.

Cantini F, Goletti D.

J Rheumatol Suppl. 2014 May;91:1-3. doi: 10.3899/jrheum.140095. No abstract available.

PMID:
24788993
20.

Management of patients with multidrug-resistant/extensively drug-resistant tuberculosis in Europe: a TBNET consensus statement.

Lange C, Abubakar I, Alffenaar JW, Bothamley G, Caminero JA, Carvalho AC, Chang KC, Codecasa L, Correia A, Crudu V, Davies P, Dedicoat M, Drobniewski F, Duarte R, Ehlers C, Erkens C, Goletti D, Günther G, Ibraim E, Kampmann B, Kuksa L, de Lange W, van Leth F, van Lunzen J, Matteelli A, Menzies D, Monedero I, Richter E, Rüsch-Gerdes S, Sandgren A, Scardigli A, Skrahina A, Tortoli E, Volchenkov G, Wagner D, van der Werf MJ, Williams B, Yew WW, Zellweger JP, Cirillo DM; TBNET.

Eur Respir J. 2014 Jul;44(1):23-63. doi: 10.1183/09031936.00188313. Epub 2014 Mar 23.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk